Ai. Pincelli et al., The serum concentration of tumor necrosis factor alpha is not an index of growth-hormone- or obesity-induced insulin resistance, HORMONE RES, 55(2), 2001, pp. 57-64
Backgound: The tumor necrosis factor alpha (TNF-a) might play a central rol
e in insulin resistance, a frequent correlate of obesity likely contributin
g to some obesity-associated complications. Adult growth hormone (GH) defic
iency syndrome (GHDA) shares with obesity excessive fat mass, hyperlipidemi
a, increased cardiovascular risk, and insulin resistance. On the other hand
, GH has been shown to induce transient deterioration of glucose metabolism
and insulin resistance when administered in normal humans and in GHDA pati
ents. No information is presently available on the relationship between ser
um TNF-alpha levels and insulin sensitivity in GHDA. Methods: We compared t
he serum TNF-a levels found in 10 GHDA patients before and after a 6-month
recombinant human GH therapy (Genotropin), in an insulin resistance prone p
opulation of 16 obese (OB) patients and in 38 normal-weight healthy blood d
onors (controls). The insulin sensitivity was assessed by a euglycemic-hype
rinsulinemic glucose clamp in all the GHDA patients and in 10 OB and in 6 c
ontrol subjects. Results: The serum TNF-alpha levels were not significantly
different in OB patients (42.2 +/- 12.81 pg/ml), in GHDA patients at basel
ine (71.3 +/- 23.97 pg/ml), and in controls (55.3 +/- 14.28 pg/ml). A sligh
t decrease of TNF-a values was noted in GHDA patients after 6 months of rec
ombinant human GH treatment (44.5 +/- 20.19 pg/ml; NS vs. baseline). The in
sulin sensitivity (M) was significantly reduced in OB patients (2.4 +/- 0.3
0 mg/kg/min) as compared with control subjects (7.5 +/- 0.39 mg/kg/min) and
in GHDA patients both at baseline (6.6 +/- 0.6 mg/kg/min) and after recomb
inant human GH therapy (5.6 +/- 0.7 mg/kg/min). The insulin sensitivity in
the GHDA patients, similar to that of controls at baseline, worsened after
recombinant human GH treatment (p < 0.05 vs. baseline; p = 0.05 vs. control
s). Linear regression analysis showed no correlation between TNF-alpha and
M values (see text) in all patient groups. Conclusions: These data indicate
that circulating concentrations of TNF-a do not reflect the degree of insu
lin resistance in obesity and GHDA. They, however, do not exclude that TNF-
a may induce insulin resistance at tissue level. Copyright (C) 2001 S. Karg
er AG, Basel.